• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

直接在有机 PLGA 溶液中药物粉碎有助于将纳米药物包封到 PLGA 微球中。

Direct drug milling in organic PLGA solution facilitates the encapsulation of nanosized drug into PLGA microparticles.

机构信息

College of Pharmacy, Freie Universität Berlin, Kelchstr. 31, 12169 Berlin, Germany.

College of Pharmacy, Freie Universität Berlin, Kelchstr. 31, 12169 Berlin, Germany.

出版信息

Eur J Pharm Biopharm. 2023 Oct;191:1-11. doi: 10.1016/j.ejpb.2023.08.006. Epub 2023 Aug 12.

DOI:10.1016/j.ejpb.2023.08.006
PMID:37579890
Abstract

The objective of this study was to prepare poly(lactide-co-glycolide) (PLGA) microparticles loaded with nanosized drug by combining non-aqueous wet bead milling and microencapsulation. 200-300 nm dexamethasone, hydrocortisone and dexamethasone sodium phosphate nanosuspensions were successfully prepared by wet bead milling the drug in dichloromethane using PLGA as a stabilizer. PLGA microparticles loaded with nanosized drugs were then prepared by a solid-in-oil-in-water (S/O/W) solvent evaporation method or solid-in-oil-in-oil (S/O/O) organic phase separation method. The microparticles were characterized by laser diffraction (LD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD) and in vitro drug release. The nanosized drugs were homogeneously distributed within the microparticle matrix and remained crystalline, however, with a decrease in crystallinity. High drug encapsulation efficiencies >80 % were achieved at theoretical drug loadings between 5 and 30 %. Drug release profiles could be controlled by varying PLGA grades/blends, microparticle size and drug loadings. Quasi-linear release profiles without the PLGA-typical slow release phase were achieved with PLGA encapsulated nanosized drug.

摘要

本研究的目的是通过结合非水湿磨和微囊化技术来制备载纳米药物的聚(丙交酯-共-乙交酯)(PLGA)微球。通过在二氯甲烷中使用 PLGA 作为稳定剂将药物湿磨,成功制备了 200-300nm 的地塞米松、氢化可的松和地塞米松磷酸钠纳米混悬剂。然后通过固-油-水(S/O/W)溶剂蒸发法或固-油-油(S/O/O)有机相分离法制备载纳米药物的 PLGA 微球。通过激光衍射(LD)、扫描电子显微镜(SEM)、透射电子显微镜(TEM)、差示扫描量热法(DSC)、X 射线粉末衍射(XRPD)和体外药物释放对微球进行了表征。纳米药物均匀分布在微球基质中,保持结晶状态,但结晶度降低。在理论药物载量为 5%至 30%之间,实现了高药物包封效率>80%。通过改变 PLGA 等级/共混物、微球粒径和药物载量,可以控制药物释放曲线。使用 PLGA 包封的纳米药物可实现准线性释放曲线,而无 PLGA 典型的缓慢释放阶段。

相似文献

1
Direct drug milling in organic PLGA solution facilitates the encapsulation of nanosized drug into PLGA microparticles.直接在有机 PLGA 溶液中药物粉碎有助于将纳米药物包封到 PLGA 微球中。
Eur J Pharm Biopharm. 2023 Oct;191:1-11. doi: 10.1016/j.ejpb.2023.08.006. Epub 2023 Aug 12.
2
A comparative study of PLGA microparticle properties loaded with micronized, nanosized or dissolved drug.载药微米化、纳米化或溶解的 PLGA 微球性质的比较研究。
Int J Pharm. 2022 Nov 25;628:122313. doi: 10.1016/j.ijpharm.2022.122313. Epub 2022 Oct 19.
3
Porous PLGA microparticles prepared with nanosized/micronized sugar particles as porogens.以纳米/微米级糖粒为致孔剂制备多孔 PLGA 微球。
Int J Pharm. 2024 Jul 20;660:124329. doi: 10.1016/j.ijpharm.2024.124329. Epub 2024 Jun 9.
4
Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.通过纳米晶体和水溶性聚合物模板技术提高灯盏花素在聚乳酸-羟基乙酸共聚物微粒中的包封率和生物利用度。
Eur J Pharm Biopharm. 2017 Jun;115:177-185. doi: 10.1016/j.ejpb.2017.02.021. Epub 2017 Mar 2.
5
Acceleration of Final Residual Solvent Extraction From Poly(lactide-co-glycolide) Microparticles.加速聚(丙交酯-乙交酯)微球中最终残留溶剂的萃取。
Pharm Res. 2024 Sep;41(9):1869-1879. doi: 10.1007/s11095-024-03744-9. Epub 2024 Aug 15.
6
Microencapsulation of ovalbumin in poly(lactide-co-glycolide) by an oil-in-oil (o/o) solvent evaporation method.采用油包油(o/o)溶剂蒸发法将卵清蛋白微囊化于聚(丙交酯-乙交酯)中。
J Microencapsul. 1996 Sep-Oct;13(5):509-18. doi: 10.3109/02652049609026036.
7
Reduction in burst release after coating poly(D,L-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer.包衣无载药聚(D,L-乳酸-共-乙醇酸)(PLGA)微球减少突释。
Pharm Dev Technol. 2012 Jan-Feb;17(1):66-72. doi: 10.3109/10837450.2010.513989. Epub 2010 Sep 20.
8
Effect of poly(lactide-co-glycolide) molecular weight on the release of dexamethasone sodium phosphate from microparticles.聚(丙交酯-乙交酯)分子量对微粒中地塞米松磷酸钠释放的影响。
J Microencapsul. 2007 Mar;24(2):117-28. doi: 10.1080/02652040701233655.
9
Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.蛋白质从聚(丙交酯-共-乙交酯)微球中的包封与释放:蛋白质和聚合物性质以及表面活性剂共包封的影响
Eur J Pharm Biopharm. 1998 May;45(3):285-94. doi: 10.1016/s0939-6411(98)00011-3.
10
Effect of Particle Size on Drug Loading and Release Kinetics of Gefitinib-Loaded PLGA Microspheres.粒径对载吉非替尼聚乳酸-羟基乙酸共聚物微球药物负载及释放动力学的影响
Mol Pharm. 2017 Feb 6;14(2):459-467. doi: 10.1021/acs.molpharmaceut.6b00896. Epub 2016 Dec 27.

引用本文的文献

1
A dataset on formulation parameters and characteristics of drug-loaded PLGA microparticles.一个关于载药聚乳酸-羟基乙酸共聚物(PLGA)微粒的制剂参数和特性的数据集。
Sci Data. 2025 Mar 1;12(1):364. doi: 10.1038/s41597-025-04621-9.